The case for investing in healthcare startups
Despite their immense potential and positive impact, such startups struggle to attract funding
SINGAPORE has seen significant growth in the number of startups and investments in the healthcare technology sector. Last year, Singapore’s healthtech startups raised US$409 million, with deal volume doubling from the previous year.
Across the globe, countries grapple with ageing populations, rising chronic disease burdens, and increasing healthcare costs. Conventional healthcare systems struggle to meet these demands – leaving room for startups that offer more efficient, cost-effective and patient-centric solutions.
Such startups harness innovations to tackle problems in traditional healthcare systems, improving patient outcomes, widening access and enhancing quality of care.
The US has long been home to healthcare innovation, while Europe has also seen significant growth in this area. Asia, with its vast population and diverse needs, has become fertile ground for healthcare startups, with Singapore, China, India and South Korea experiencing a surge in innovative ventures.
Transforming healthcare through technology
Startups play pivotal roles in using cutting-edge technologies such as artificial intelligence (AI) to address complex healthcare challenges, including chronic disease management. For instance, Singapore startup Awak Technologies has developed an AI prediction tool to help clinicians assess a patient’s risk of kidney disease progression and improve care.
Other startups are developing remote monitoring devices, smart medication dispensers and personalised care platforms that empower patients to manage their conditions from the comfort of their homes.
Biofourmis has developed tools to monitor patients at home and deliver care remotely. This not only improves the quality of life for those with chronic illnesses, but also reduces the burden on healthcare facilities and professionals.
Healthcare startups also step in where infrastructure is lacking. In China, digital health platform WeDoctor offers telemedicine services and online pharmacies. Similarly, Halodoc in Indonesia offers remote consultations and medicine delivery to make healthcare more accessible in rural and underserved areas.
Another area that startups serve is mental health. Singapore-based Intellect offers a mental health app with self-care programmes, online therapy and coaching, making mental health support accessible to a broader audience.
Such platforms break down barriers to mental healthcare by offering anonymity, affordability and convenience, which are particularly important in regions where mental health stigma persists.
The struggle for funds
Despite their immense potential and positive impact, healthcare startups face numerous challenges: securing funding, navigating regulatory frameworks, conducting clinical trials and integrating into existing healthcare systems.
First, funding is a major challenge. Investors often hesitate when it comes to this sector, due to the perceived risks associated with healthcare innovation. Unlike other industries, healthcare startups require substantial initial investments to support research and development, clinical trials, regulatory compliance and market entry.
Convincing investors to fund such ventures requires a deep understanding of the healthcare landscape, a compelling business model, and a strong value proposition.
A second challenge is navigating complex regulatory frameworks. The healthcare industry is heavily regulated to ensure patient safety and maintain quality standards. However, these regulations can be difficult and time-consuming to comply with, especially for startups with limited resources.
It is essential for startups to stay abreast of the regulatory landscape, engage with regulatory bodies, and seek guidance from experts to navigate these complexities.
Third is the need to conduct clinical trials and obtain necessary validation.
Investors often prioritise technologies with strong clinical evidence, in order to mitigate risks and ensure the efficacy and safety of the proposed solutions. However, conducting clinical trials can be a lengthy and costly process, especially for early-stage startups.
Creating avenues for early-stage validation, such as streamlined regulatory pathways and partnerships with research institutions, can facilitate the development of clinical evidence and increase investor confidence.
Finally, there is the hurdle of integrating into existing systems. The healthcare industry has traditionally been slow to adopt new technologies due to resistance to change, legacy systems and interoperability issues.
Startups must demonstrate how their innovations can seamlessly integrate into existing workflows, enhance healthcare delivery, and improve outcomes. Partnering early with healthcare providers, payers and other stakeholders is essential to ensure successful adoption and integration of these new technologies, while staying abreast of their needs.
Investor mindsets and priorities
The significance of investing in healthcare technology startups cannot be overstated. These ventures have the potential to introduce ground-breaking solutions that can transform healthcare access, quality and affordability on a global scale.
Both investor mindsets and the evaluation criteria for healthcare startups need to be aligned with the speed of innovation.
Investors should recognise the unique chance to transform patient outcomes, even while weighing traditional financial metrics such as scalability and market demand.
Venture capitalists play a vital role in fostering the growth of healthcare startups by providing not only financial support, but also strategic guidance, industry connections and mentorship.
Understanding investor mindsets and showcasing this sector’s profitability potential will help to attract more funding and thus enable startups to bring their solutions to market.
Investing in healthcare startups is not only a strategic financial decision but also a social responsibility. By nurturing these startups and providing them with the necessary resources, investors can help them reach their full potential, paving the way for a brighter future in healthcare.
The writer is a director at Vickers Venture Partners
